ANIX News and Press, Anixa Biosciences Inc. From 03/22/21

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock PR Newswire SAN JOSE, Calif. , March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc.  (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment an...

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy PR Newswire SAN JOSE, Calif. , March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preven...

The European Patent Office has issued the first European patent for Anixa Biosciences' (ANIX) novel ovarian cancer vaccine technology. The patent is titled, "Ovarian Cancer Vaccines".This technology was invented and developed at Cleveland Clinic and Anixa is the worldwide licensee.  ...

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology Technology invented and developed at Cleveland Clinic PR Newswire SAN JOSE, Calif. , March 12, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASD...

Anixa Biosciences (ANIX) announces that the European Patent Office has issued the first European patent for Anixa's novel CAR-T cancer treatment technology.The CAR-T therapy has been licensed from The Wistar Institute and is being developed in partnership with Moffitt Cancer Center.The p...

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy PR Newswire SAN JOSE, Calif. , March 4, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer...

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire SAN JOSE, Calif. , Feb. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer ...

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates PR Newswire SAN JOSE, Calif. , Feb. 16, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and ...

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference PR Newswire SAN JOSE, Calif. , Jan. 13, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infect...

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire SAN JOSE, Calif. , Jan. 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and in...